2seventy bio Inc.

NASDAQ: TSVT · Real-Time Price · USD
5.00
0.00 (0.00%)
At close: May 12, 2025, 3:59 PM

2seventy bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
92.36M 71.24M 59.98M 111.86M 56.79M 74.96M 90.23M 95.99M 193.63M 71.03M 127.02M 269.87M 270.89M 130.41M n/a n/a n/a
Short-Term Investments
78.02M 103.51M 132.41M 90.01M 124.59M 142.03M 160.39M 186.85M 146.3M 195.24M 196.09M 88.06M 106.97M 134.64M n/a n/a n/a
Long-Term Investments
2.99M 8.87M n/a n/a n/a 4.82M 33.66M 23.71M 1.43M 1.41M 1.41M 40.64M 74.68M 97.12M n/a n/a n/a
Other Long-Term Assets
40.6M 39.35M 38.34M 39.61M 38.24M 38.14M 37.89M 37.6M 37.59M 38.39M 38.28M 39.03M 37.75M 38.59M 6.24M 5.92M n/a
Receivables
23.93M 7.78M 22.27M 18.13M 11.98M 13.41M 19.52M 44.1M 41.25M 20.96M 12.04M 12.16M 16.93M 17M 16.14M 11.37M n/a
Inventory
n/a n/a n/a n/a n/a -13.41M -19.52M -44.1M -41.25M n/a n/a n/a -16.93M -87.25M n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a 12.79M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 7.25M n/a
Total Current Assets
198.58M 187.26M 218.48M 224.87M 212.84M 237.76M 277.25M 333.67M 389.82M 300.88M 349.42M 383.89M 412.8M 291.56M 24.59M 18.63M n/a
Property-Plant & Equipment
232.12M 238.15M 240.96M 247.18M 253.55M 278.11M 285.23M 291.74M 294.42M 296.62M 300.11M 304.14M 305.86M 310.45M 139.06M 253.94M n/a
Goodwill & Intangibles
5.71M 5.88M 6.06M 6.24M 6.42M 6.59M 6.77M 19M 19.18M 19.36M 19.54M 19.71M 20.83M 21.95M 23.07M 25.25M n/a
Total Long-Term Assets
281.42M 292.25M 285.37M 293.02M 298.21M 327.66M 363.55M 372.05M 352.62M 355.78M 359.33M 403.52M 439.12M 468.11M 168.36M 285.12M n/a
Total Assets
480M 479.51M 503.85M 517.9M 511.05M 565.43M 640.81M 705.71M 742.44M 656.66M 708.74M 787.41M 851.92M 759.67M 192.96M 303.74M n/a
Account Payables
5.18M 1.05M 5.08M 3M 8.8M 6.03M 5.31M 6.27M 13.4M 7.21M 7.98M 6.68M 13.65M 6.02M 6.2M 18.98M n/a
Deferred Revenue
n/a n/a 457K 888K 16.34M 15.4M 13.03M 12.64M 8.48M 3M 40.76M 40.76M 5M 5M 25.76M 25.76M n/a
Short-Term Debt
n/a n/a n/a n/a n/a 12.66M n/a 11.87M 11.48M 11.16M 10.8M 10.73M 10.07M 9.77M 14.48M n/a n/a
Other Current Liabilities
4.88M 7.12M 10.79M 10.81M 9.06M 8.39M 22.2M 13.93M 27.54M 32.41M 40.66M 56.75M 52.74M 45.87M 42.46M 39.1M n/a
Total Current Liabilities
41.4M 40.09M 44.09M 47.2M 60.41M 59.78M 68.01M 66.89M 76.93M 79.79M 79.9M 99.01M 106.31M 98.39M 106.08M 103.78M n/a
Long-Term Debt
n/a n/a n/a n/a n/a 244.01M n/a 251.71M 255.47M n/a 262.49M n/a 269.29M 272.45M 99.82M 104.08M n/a
Other Long-Term Liabilities
1.65M 1.26M n/a n/a 685K -241.6M 2.41M -249.3M -253.07M 2.4M -260.07M 43.5M -266.15M -269.19M -54.35M -56.88M n/a
Total Long-Term Liabilities
224.65M 228.61M 231.65M 235.89M 243.21M 250.35M 266.38M 271.32M 264.18M 266.4M 305.67M 309.41M 298.19M 301.46M 145.29M 151.27M n/a
Total Liabilities
266.04M 268.7M 275.74M 283.09M 303.61M 310.13M 334.38M 338.22M 341.11M 346.2M 385.56M 408.42M 404.5M 399.85M 251.37M 255.06M n/a
Total Debt
239.76M 243.72M 247.45M 251.4M 253.08M 256.67M 260.16M 263.58M 266.95M 270.17M 273.29M 276.64M 279.36M 282.21M 114.3M 118.17M n/a
Common Stock
5K 5K 5K 5K 5K 5K 5K 5K 5K 4K 4K 4K 4K 2K n/a 48.69M n/a
Retained Earnings
-567.98M -568.46M -548.94M -539.01M -563.89M -511.22M -454.39M -382.76M -340.67M -293.65M -270.5M -202.63M -125.2M -39.49M n/a n/a n/a
Comprehensive Income
54K 89K 305K -236K -336K -204K -916K -1.43M -1.95M -2.88M -3.89M -3.38M -2.8M -712K n/a n/a 74.63M
Shareholders Equity
213.96M 210.81M 228.1M 234.8M 207.44M 255.3M 306.42M 367.5M 401.32M 310.47M 323.18M 378.98M 447.42M 359.82M -58.41M 48.69M 74.63M
Total Investments
81.01M 112.38M 132.41M 90.01M 124.59M 146.85M 194.05M 224.45M 183.89M 196.65M 197.5M 128.7M 181.66M 459.31K n/a n/a n/a